Journals / MN Oftalmoloji / 2002 / Cilt: 9 - Sayı: 1

Does betaxolol twice daily prevent early glaucomatous perimetric damages in ocular hypertension

Oküler hipertansiyonlu olgularda betaksolol kullanımının, glokomatöz görme alanı defektlerini önlemedeki etkisi

Pages
24–25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION: We found no effect of betaxolol twice daily to prevent early glaucomatous perimetric damages in ocular hypertension cases in one year.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:PURPOSE: To investigate the effect of betaxolol %0.5 applied twice daily on early glaucomatous perimetric damages, in ocular hypertension cases MATERIAL AND METHODS: Results of 100 eyes of 50 patients who had ocular hypertension in which intraocular pressure was between 22-25mmHg, none had cup/disc ratio greater than 0.2 and glaucomatous perimetric defects.
📊
Key Findings & Data:RESULTS: After one year, in 5 of 50 eyes who had received betaxolol therapy and 6 of 50 eyes who had had no therapy, early glaucomatous perimetric defects were detected.
💡
Conclusion & Impact:CONCLUSION: We found no effect of betaxolol twice daily to prevent early glaucomatous perimetric damages in ocular hypertension cases in one year.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Oküler hipertansiyon · İleriye dönük çalışma · Görme alanları

Abstract

PURPOSE: To investigate the effect of betaxolol %0.5 applied twice daily on early glaucomatous perimetric damages, in ocular hypertension cases MATERIAL AND METHODS: Results of 100 eyes of 50 patients who had ocular hypertension in which intraocular pressure was between 22-25mmHg, none had cup/disc ratio greater than 0.2 and glaucomatous perimetric defects. Twentyfive patients were chosen randomly to receive betaxolol therapy twice daily, while others had no treatment. After one year, perimetric changes were investigated in all of the eyes. RESULTS: After one year, in 5 of 50 eyes who had received betaxolol therapy and 6 of 50 eyes who had had no therapy, early glaucomatous perimetric defects were detected. CONCLUSION: We found no effect of betaxolol twice daily to prevent early glaucomatous perimetric damages in ocular hypertension cases in one year.

Özet

AMAÇ: Oküler hipertansiyonlu olgularda %0.5'lik betaksolol kullanımının, zaman içinde gelişebilen glokomatöz görme alanı defektlerini önlemedeki etkisinin incelenmesi GEREÇ VE YÖNTEM: Haziran 1997-Ocak 2001 dönemleri arasında izlenen; göz içi basınç değerleri 22-25 mmHg değerleri arasında olup c/d oranları normal ve perimetrik incelemelerinde glokomatöz hasar saptanmayan 50 hastanın 100 gözü prospektif olarak incelenmiştir. Randomize olarak 25 hastanın 50 gözüne %0.5'lik betaksolol sabah akşam önerilip, kalan 25 hastanın 50 gözüne ise herhangi bir tedavi başlanmamıştır. Bir yıl sonra yapılan perimetrik incelemede, her iki gruptaki erken glokomatöz defektler karşılaştırılmıştır. BULGULAR: Bir yılın sonunda, betaksolol kullanılan 50 gözün 5'ünde (%10); tedavi almayan 50 gözün 6'inde (%12) nazal step, arkuat skotom, periferik daralma ve kör nokta genişlemesi gibi erken glokomatöz defektler saptanmıştır. SONUÇ: Oküler hipertansiyonlu olgularda betaksolol kullanımının, bir yıllık dönemde, glokomatöz görme alanı defektlerini önlemede anlamlı etkisi bulunmamıştır.

🔖

Cite This Article

ELGİN, K. U., İLHAN, B., BATMAN, A., GÜRSEL, R., ÇANKAYA, B., ZİLELİOĞLU, O. (2002). Does betaxolol twice daily prevent early glaucomatous perimetric damages in ocular hypertension. MN Oftalmoloji, Cilt: 9 - Sayı: 1, 24–25. https://ajindex.com/articles/296265